<DOC>
	<DOCNO>NCT03009487</DOCNO>
	<brief_summary>A multi-center , randomize , double-blind , phase III clinical trial evaluate efficacy safety Olmesartan/Amlodipine/Rosuvastatin combination treatment patient concomitant hypertension hyperlipidemia</brief_summary>
	<brief_title>A Clinical Trial Evaluate Efficacy Safety Olmesartan/Amlodipine/Rosuvastatin Combination Treatment Patients With Concomitant Hypertension Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine Besylate , Olmesartan Medoxomil Drug Combination</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Age 20 80 year patient hypertension hyperlipidemias orthostatic hypotension History ventricular tachycardia , atrial fibrillation uncontrolled diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>